Hungry for the latest in foodservice trends and solutions? The Culinary 360 Podcast is your one-stop podcast, brought to you by Ignite Foodservice Solutions, where we dish out insights, challenges, and market updates for all things foodservice related. Join our fiery culinary team as we bring you fresh ideas, resources, and host special guests.
…
continue reading
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is p ...
…
continue reading
Keep up to date with the latest news, recruitment advice and hot topics in Physical Industry such as manufacturing, engineering, sustainable energy.
…
continue reading
We share the latest packaging and processing industry insights, research and innovations to help you advance your business. Search for unPACKed with PMMI en español, our new podcast created by and for the Latin American market!
…
continue reading
Success stories from professionals in virtually every industry
…
continue reading
A podcast about bicycling, cycling culture, bikepacking, gravel riding, bike touring and the bike industry.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
From The Bench To The Boardroom with ImmunityBio's Enrique Diloné
1:06:39
1:06:39
Play later
Play later
Lists
Like
Liked
1:06:39
We love to hear from our listeners. Send us a message. While organic chemistry lectures caused many of his peers at NYU to wring their hands, gnash their teeth, and question life choices, then-19-year-old Enrique Diloné ate those classes for lunch. They inspired him to earn a Seton Hall Ph.D. in chemistry, and to go to work as a big bio research sc…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
From Bay View to Hell's Kitchen with Chef Adam Pawlak | Episode 7
1:02:53
1:02:53
Play later
Play later
Lists
Like
Liked
1:02:53
Join us on this episode of The Culinary 360 Podcast as we dive into the incredible journey of Chef Adam Pawlak, owner and chef at Egg & Flour Pasta Bar in Bay View, Wisconsin. Chef Adam's exceptional talent has not only earned him a massive social media following but also appearances on shows like “Beat Bobby Flay” and “Hell's Kitchen,” Season 19. …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Achieving Rapid Production Efficiency in Manufacturing with Vertical Startups
14:56
14:56
Play later
Play later
Lists
Like
Liked
14:56
In this episode, we explore vertical startups in manufacturing. We discuss achieving rapid production efficiency through transparency, pre-planning, process optimization, and early OEM involvement. Hear insights from recent top-to-top discussions and learn strategies for overcoming common challenges in the industry. Whether you're a CPG or OEM, thi…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
First AI Antibody In Humans with Aulos' Aron Knickerbocker
1:08:52
1:08:52
Play later
Play later
Lists
Like
Liked
1:08:52
We love to hear from our listeners. Send us a message. Data drives decision-making at Aulos Bioscience. It's also driven the career trajectory of its CEO. On this week's episode of the Business of Biotech podcast, we get an introspective walk through Aron Kinickerbocker's strategically-orchestrated career path, from his early days in the labs at Br…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Drug Delivery Differentiators with Syncromune's Eamonn Hobbs
1:12:31
1:12:31
Play later
Play later
Lists
Like
Liked
1:12:31
We love to hear from our listeners. Send us a message. Syncromune's Sync-T solid tumor therapeutic platform is, in a word, complex. The company's three phase 1 programs combine T-cell science with a proprietary drug delivery device to target solid tumors, specifically metastatic breast, non-small-cell lung, and castrate-resistant prostate cancers. …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Topical Ocular Biologics with Claris Bio's Clarke Atwell
58:06
58:06
Play later
Play later
Lists
Like
Liked
58:06
We love to hear from our listeners. Send us a message. Built on the back of hepatocyte growth factor discoveries by Harvard Drs. Reza Dana and Sunil Chauhan, ClarisBio is rewriting the ophthalmology rulebook. CEO Clark Atwell acknowledges that it's not the first to bring topically-administered biologic therapies to the front of the eye, but if succ…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
C&G Regulatory Guidance with Lineage Therapeutics' Brian Culley
1:04:02
1:04:02
Play later
Play later
Lists
Like
Liked
1:04:02
We love to hear from our listeners. Send us a message. When we last caught up with Brian Culley, CEO at Lineage Cell Therapeutics, it was January, 2021. A pandemic was raging. His company was moving mountains to keep its OpRegen dry AMD clinical trial together, and did so despite lockdowns that kept a largely aged patient population from setting fo…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Breaking Barriers to Authentic Communication and Personal Growth
19:37
19:37
Play later
Play later
Lists
Like
Liked
19:37
In this episode we discuss overcoming barriers to authentic communication including imposter syndrome, perfectionism, and people-pleasing, with strategies like grounding oneself and prioritizing important values. This episode also emphasizes self-awareness in managing feedback, adapting communication styles, and balancing authenticity with understa…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
True DEI Value in Biopharma with Arcellx's Rami Elghandour
1:04:08
1:04:08
Play later
Play later
Lists
Like
Liked
1:04:08
We love to hear from our listeners. Send us a message. The cell therapy company Arcellx has, by any and every measure, been outperforming its peers. Its stock has rallied on the back of the strong performance of its multiple myeloma candidate, and the promise of its AML, MDS, and solid tumor pipelines is attracting the kind of interest it takes to …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Custom Dry Blends that Taste Like Scratch with Chef Jerry McDonald | Episode 6
48:19
48:19
Play later
Play later
Lists
Like
Liked
48:19
Chef Jerry McDonald is currently the Vice President of Culinary at Midas Foods International, and he is responsible for the development of some of the finest, custom, chef-inspired, dry-mix sauces, glazes, gravies, bases, drinks, and desserts. An incredibly passionate culinary ambassador, Chef Jerry and his culinary team work with restaurant chains…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Mission-Driven Dementia Funding with DDF's Jonathan Behr
55:46
55:46
Play later
Play later
Lists
Like
Liked
55:46
We love to hear from our listeners. Send us a message. If there's anyone qualified to analyze an early-stage therapeutic technology and place bets with other people's money, it's scientist-turned-venture capitalist Jonathan Behr, Ph.D. He built a distinguished venture capital career on the back of an MIT Ph.D. in biological engineering, having co-f…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Navigating Change: Insights on Employees, Strategy, and Seizing Opportunities
14:16
14:16
Play later
Play later
Lists
Like
Liked
14:16
In this episode, we speak with Former CEO, Taco Bell Mark King. King discusses the critical role of leaders in shaping the future of organizations. He emphasizes that while “doers” and “managers” focus on current tasks and executing plans, leaders are responsible for envisioning and preparing for the future. He shares four key strategies for naviga…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
ADCs Ignited with Daiichi Sankyo Inc.'s Ken Keller
1:04:06
1:04:06
Play later
Play later
Lists
Like
Liked
1:04:06
We love to hear from our listeners. Send us a message. Just a few years ago, Daiichi Sankyo wasn't considered a player in the oncology therapeutics space, and it certainly wasn't a player in ADCs. But then, just a few years ago, who was? Fast forward to 2023, and we see an ADC arena that drove nearly $100 billion in M&A, licensing, and partnership …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Accelerating ADCs with Mythic Therapeutics' Brian Fiske, Ph.D.
56:38
56:38
Play later
Play later
Lists
Like
Liked
56:38
We love to hear from our listeners. Send us a message. Mythic Therapeutics Chief Scientific Officer and co-founder Brian Fiske, Ph.D. broke some unwritten protocol with his rapid and multifaceted transition from academia to industry. He calls his many, and sometimes concurrent, early experiences as an MIT Ph.D. student, a Flagship Ventures Fellow, …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Ignite Your Business Success with a Powerful Culture Transformation
17:14
17:14
Play later
Play later
Lists
Like
Liked
17:14
This episode explores the evolution of workplace culture over the past 15 years, moving from superficial activities to a strategic focus. The Great Resignation accelerated this shift as employees became more discerning about their work environment. Notter highlights that cultural change can happen quickly and should be continuous to align with orga…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Anti-CDMO with CTMC's Jason Bock, Ph.D. and KSQ's Thomas Leitch
57:35
57:35
Play later
Play later
Lists
Like
Liked
57:35
We love to hear from our listeners. Send us a message. This isn't your typical drug sponsor + CDMO story. In fact, CTMC's Jason Bock, Ph.D. says you shouldn't even classify his company a CDMO. He's not wrong. While some of the company's services aren't dissimilar from those offered by a contract developer, CTMC began with a more fundamental mission…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Culinary Meets Cocktails with Stuart Jensen | Episode 05
42:55
42:55
Play later
Play later
Lists
Like
Liked
42:55
Tune into Episode 5 of The Culinary 360 Podcast where we chat with Stuart Jensen, a master of culinary and cocktail innovation in Denver. From his early days as a line cook to co-owning the Curio Bar and Roger's Liquid Oasis, Stuart shares how he blends kitchen technology farm-fresh ingredients, and his knowledge of flavor combinations into his cel…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
A New Prescription For PBMs with Allan Shaw
40:13
40:13
Play later
Play later
Lists
Like
Liked
40:13
We love to hear from our listeners. Send us a message. Back by popular demand, biopharma industry opinionator extraordinaire Allan Shaw rejoins the Business of Biotech to expose the murky role Pharmacy Benefit Managers (PBMs) play in the last, costly mile of the drug distribution supply chain. Allan pulls no punches in his criticism of the current …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Future of AI: Turning Fears into Frontiers
17:28
17:28
Play later
Play later
Lists
Like
Liked
17:28
In this episode we dive into the benefits of artificial intelligence (AI) with Tom Morrison. We address common fears like job loss and the potential for misuse while encouraging companies to adopt AI to help shape a better future. Morrison says AI isn't about cutting jobs but about improving efficiency and expanding what we can do. See more innovat…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
New Apps For AI in mRNA With Anima Biotech's Yochi Slonim
59:10
59:10
Play later
Play later
Lists
Like
Liked
59:10
We love to hear from our listeners. Send us a message. From San Francisco’s Silicon Valley to Tel Aviv’s Silicon Wadi, software business entrepreneur Yochi Slonim made a name for himself in global tech hubs around the globe. Notably, he was co-founder of billion-dollar Mercury Interactive, which HP acquired for $4.5 billion, and previous to that a …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Circular RNA with Orna Therapeutics' Tom Barnes, Ph.D. and Advancing RNA's Anna Rose Welch
59:11
59:11
Play later
Play later
Lists
Like
Liked
59:11
We love to hear from our listeners. Send us a message. As if Orna Therapeutics' CEO Thomas Barnes, CEO isn't a enough to draw you in to the Business of Biotech, we teamed up with Advancing RNA Editorial & Community Director Anna Rose Welch to co-host this week's episode. Together, Anna Rose and I press Dr. Barnes on his transition from academia to …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Economic Insights for Tomorrow: A Talk with Brian Beaulieu
14:40
14:40
Play later
Play later
Lists
Like
Liked
14:40
In this episode, Brian Beaulieu discusses the economic outlook for the mid-2020s and strategies for businesses in the packaging and processing industries. We explore how technological advancements and strategic planning can address challenges like labor shortages and inflation. Brian also offers insights on global economic trends and preparation fo…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Physician + Biotech Builder with Tome Biosciences' Rahul Kakkar, M.D.
1:01:30
1:01:30
Play later
Play later
Lists
Like
Liked
1:01:30
We love to hear from our listeners. Send us a message. Novel technologies aren’t interesting to Rahul Kakkar, M.D. unless they help patients. Sounds rational, but it’s actually a unique perspective in a platform-crazed biotech industry. Dr. Kakkar’s worldview is shaped by his work as a physician—work he continues at Brigham and Women’s Hospital eve…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Culinary Innovation & Culture: Chat with Corporate Chef Consultant Karen Kaehler | Episode 04
49:23
49:23
Play later
Play later
Lists
Like
Liked
49:23
Welcome to episode four of The Culinary 360 Podcast! Today, our Ignite culinary team talks with Karen Kaehler, a corporate chef and culinary consultant. She's worked in a variety of kitchens — the South Beach restaurants of Norman Van Aken, cruise ships in Scandinavia, teaching in classrooms at Johnson & Wales University, and corporate test kitchen…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Commercial Readiness with ImmunityBio's Bobby Reddy, M.D.
56:54
56:54
Play later
Play later
Lists
Like
Liked
56:54
We love to hear from our listeners. Send us a message. This episode of the Business of Biotech begins with a personal story about my dad and the standard of care in bladder cancer, before shifting to the work that Dr. Bobby Reddy and his team at ImmunityBio are doing to change that standard of care. They're painfully close. Dr. Reddy, Chief Medical…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Designing Tomorrow: The Circular Economy's Role in Sustainable Packaging
18:58
18:58
Play later
Play later
Lists
Like
Liked
18:58
On this episode where we delve into the circular economy's role in sustainable packaging with our guest, Tim Grant. As director at Lifecycles, Grant sheds light on the importance of integrating economic considerations into environmental strategies, highlighting how the circular economy offers a more accessible framework for both industry and govern…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Precision Drug Delivery with Ampersand Biomedicines' Jason Gardner, D.Phil.
49:47
49:47
Play later
Play later
Lists
Like
Liked
49:47
We love to hear from our listeners. Send us a message. Ampersand Biomedicines CEO Jason Gardner, D.Phil. first took the leap from a global pharmaceutical giant to a startup at the forefront of transplant medicine innovation. Since that time, he's seen most of the ups and the downs that come with biotech leadership, and in his latest venture with th…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Funding Alzheimer's Tx Dev with ADDF's Karen Harris
40:16
40:16
Play later
Play later
Lists
Like
Liked
40:16
We love to hear from our listeners. Send us a message. We've really been looking forward to dropping this episode with Karen Harris, Chief Financial Officer and Head of Mission-Related Investing at the Alzheimer's Drug Discovery Foundation. While the markets have warmed a bit since we recorded this episode, Karen's thoughtful perspective on the som…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The AI Impact with Generate:Biomedicines' Mike Nally
1:13:54
1:13:54
Play later
Play later
Lists
Like
Liked
1:13:54
We love to hear from our listeners. Send us a message. Few drug discovery and development concepts are as hyped, and as such, draw as much polarity from drug developers, as machine learning and artifical intelligence. One company on the bullish end of the spectrum is Flagship Pioneering's Generate Biomedicines, which bills itself at the "intersecti…
…
continue reading
In this episode, Jorge Izquierdo, vice president of market development for PMMI joins us for a deep dive into PMMI's latest reports on the world packaging machinery market and the guide to global markets which provide invaluable insights into market sizes, growth expectations, and detailed analyses of the packaging machinery import landscape. Tune …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Strategic Deals with CinRx's Gavin Samuels, M.D.
47:52
47:52
Play later
Play later
Lists
Like
Liked
47:52
We love to hear from our listeners. Send us a message. Gavin Samuels, M.D. found his work as an intensive care physician boring. After earning his M.D., he did that for a few years before moving into intensive care management roles. It wasn't until he left the hospital and entered biopharma that he found his footing, cutting his teeth in business d…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Feeding Young Minds: Managing School Foodservice with Matt Davis | Episode 03
38:53
38:53
Play later
Play later
Lists
Like
Liked
38:53
In this episode of The Culinary 360 Podcast, join us, the Ignite Foodservice culinary team, and special guest Matt Davis, the Foodservice Director at Galesburg Unified School District in Illinois, as we talk school nutrition and the innovative strategies to enhance student dining experiences. Discover what it is like to manage a large-scale foodser…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Serial Success With Triumvira's Rob Williamson
31:32
31:32
Play later
Play later
Lists
Like
Liked
31:32
We love to hear from our listeners. Send us a message. Rob Williamson's mind and hands have shaped more than 20 biotech startups, leading some to IPO and landing others firmly in Big Bio through acquisition by companies like Merck. Hanging around as many successful exits as Williamson has seen, one might become expert via osmosis. But Williamson is…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Shifting Gears in Sales: Embracing the New Buyer Journey in Packaging
29:43
29:43
Play later
Play later
Lists
Like
Liked
29:43
In this latest episode we dive into a discussion with sales expert Matt Neuberger about evolving sales trends particular to the packaging industry. Matt highlights a paradigm shift where buyers now favor a "sales rep free" experience, preferring to research and make decisions independently. As a result, he emphasizes the importance of sales reps be…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Innovator's Dilemma with Lumen Bioscience's Brian Finrow, J.D.
50:43
50:43
Play later
Play later
Lists
Like
Liked
50:43
We love to hear from our listeners. Send us a message. In biotech, when "one of these things doesn't look like the other one," it can be a blessing or a curse. On one hand, scientific novelty is praised and rewarded. On the other, unfamiliarity breeds skepticism from the investment community. Brian Finrow, J.D. embraces that reality and the challen…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Precision Radiopharmaceuticals with Ratio's Jack Hoppin, Ph.D.
40:38
40:38
Play later
Play later
Lists
Like
Liked
40:38
We love to hear from our listeners. Send us a message. Multimodal approaches to the delivery of radiologically active compounds have created a fertile environment to for players in the space to put on a precision medicine clinic, so to speak. What’s more, Radiopharmaceuticals create a unique business opportunity given the closely-related and necess…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Emerging Trends in Pharma Packaging: AI's Rise and Machinery Advances at PACK EXPO East
9:18
9:18
Play later
Play later
Lists
Like
Liked
9:18
In this episode we delve into the current and emerging trends within the pharmaceutical packaging machinery industry, with a special focus on AI's impact and the shift towards more reliable machinery. See the latest in pharmaceutical packaging machinery live and up-close at PACK EXPO East this March. See more innovation in packaging and processing …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Managing Mergers With Sail Biomedicines' Guillaume Pfefer, Ph.D.
51:07
51:07
Play later
Play later
Lists
Like
Liked
51:07
We love to hear from our listeners. Send us a message. While you might be aware that Sail Biomedicines was just formed up in Q4 of last year, the product of Flagship Pioneering’s decision to merge Senda Biosciences and Laronde, two of its programmable medicine platform companies. What you likely haven’t heard is the inside story on how the merger w…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Up Close and Personal with the Ignite Culinary Team | Episode 02
26:56
26:56
Play later
Play later
Lists
Like
Liked
26:56
Welcome to Episode 2 of The Culinary 360 Podcast! Learn about the personal journeys of three remarkable chefs from the Ignite Foodservice Solutions’ culinary team. Each of us shares our unique story, revealing the pivotal moments and inspirations that led to a career in the culinary arts. We all have a profound love for being in the kitchen and usi…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Reprogramming Human Cells With bit.bio's Mark Kotter, M.D.
45:51
45:51
Play later
Play later
Lists
Like
Liked
45:51
We love to hear from our listeners. Send us a message. The concept of programmable biology is fueling a new breed of biotech, one that requires the marriage of computational and traditional science (and both computational and traditional scientists) on the entire journey from discovery to commercial. Bit.bio is exemplary of this new breed. Its CEO,…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Discover the Future of Automation at PACK EXPO East
15:33
15:33
Play later
Play later
Lists
Like
Liked
15:33
In this episode, we explore the booming trends in packaging and processing automation – from insightful industry reports to the cutting-edge technologies embraced by CPG companies. Get a sneak peek into what PACK EXPO East has to offer, where attendees can explore the latest in automation capabilities, and attend educational sessions right on the s…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Inhalable mRNA with Ethris' Carsten Rudolph, Ph.D.
46:59
46:59
Play later
Play later
Lists
Like
Liked
46:59
We love to hear from our listeners. Send us a message. Without doubt, the grand and collaborative experiment that was the mRNA COVID vaccine contributed mightily to the pandemic response and continues to save lives untold. It also demonstrated the collective power of public/private partnership in biopharma. Having acknowledged that, no first iterat…
…
continue reading
We love to hear from our listeners. Send us a message. The Business of Biotech took a trip to San Francisco for the JP Morgan Healthcare Conference, that most target-richest of environments for those of us who like talking shop with biotech builders. The results of that trip will feed the next several weeks of Business of Biotech podcast programmin…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Digital Shift: How Remote Trends are Revolutionizing the Industry
18:03
18:03
Play later
Play later
Lists
Like
Liked
18:03
Explore the dynamic world of remote services in the packaging and processing industry, delving into insights from PMMI's latest white paper on "2024 Trends in Remote Services and Monitoring." Discover the driving forces behind the adoption of remote services, including reducing machine downtime, optimizing performance, and gaining a glimpse into th…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Multimodal R&D Management with Incyte's Jim Lee, M.D., Ph.D.
50:31
50:31
Play later
Play later
Lists
Like
Liked
50:31
We love to hear from our listeners. Send us a message. Success at multimodal, multi-indication, deep-pipelined Incyte—where commercial operations are as familiar as pre-discovery activity is—begins at the earliest opportunity to achieve research and discovery efficiencies. The company’s a bit larger than those we typically cover on the Business of …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Building A Biotech Hub with Intellia Therapeutics' John Leonard, M.D.
55:03
55:03
Play later
Play later
Lists
Like
Liked
55:03
We love to hear from our listeners. Send us a message. We spend a lot of time talking with our guests about building biotech companies. That’s true of this episode too, but today we’re taking a step further with John Leonard, M.D., longtime CEO at Intellia Therapeutics. In addition to how he’s built late-clinical stage Intellia, Dr. Leonard shares …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Sealing the Deal: Unwrapping the Art of Negotiation
41:47
41:47
Play later
Play later
Lists
Like
Liked
41:47
In this episode we delve into the crucial topic of negotiation. Negotiation is a skill that holds significant importance in career development, yet it's not always innate for many individuals. The question we're exploring today is: Can negotiation be learned? Joining the pod is Angela Hall, an expert in negotiation skills development and Joyce Long…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Art Of The Pivot with Elevation Oncology's Joe Ferra
49:56
49:56
Play later
Play later
Lists
Like
Liked
49:56
We love to hear from our listeners. Send us a message. Relatively new CEO Joseph Ferra has orchestrated some pretty significant change at Elevation Oncology in the two(ish) years since the Business of Biotech last hosted the company. In that short time, Ferra advance from CFO to CEO, a move that aligned very closely with the company's difficult dec…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Sparking Success: Exploring School Foodservice with Katie Cossette | Episode 01
44:35
44:35
Play later
Play later
Lists
Like
Liked
44:35
Welcome to the Culinary 360 Podcast, where we dive into the world of foodservice with Ignite Foodservice Solutions' team of expert chefs! In our first episode, we sit down with Katie Cossette, a Registered Dietitian and School Nutrition Specialist who oversees foodservice for St. Vrain Valley School District in Colorado. With over 10 years of exper…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
CDMO Collab with Scorpius BioManufacturing's Steve Lavezoli + Fina Biosolutions' Dr. Andrew Lees
51:41
51:41
Play later
Play later
Lists
Like
Liked
51:41
We love to hear from our listeners. Send us a message. A new year marks a fresh start for biotech partnerships, and to kick off 2024, we're highlighting a good one. Fina Biosolutions' Dr. Andrew Lees recently signed on with Scorpius BioManufacturing to support his company's growth plan. On today's episode of the Business of Biotech, Lees sits down …
…
continue reading